President Donald Trump is set to outline a new initiative aimed at reducing prescription medication costs on Friday. The administration expects to announce that Medicaid programs across all 50 states will gain access to “most favored nation” pricing for specific pharmaceuticals.
The president will be accompanied by multiple state governors for the announcement in the Oval Office. This move represents another phase in the Trump administration’s ongoing efforts to lower the financial burden of drugs on consumers and government programs.
Great idea! But will patients on expensive treatments see any real change, or is this just political theater?
Does this apply to brand-name drugs only? The devil’s in the details, and I’m skeptical about how much savings we’ll really see.
I hope this actually lowers costs for families. We’ve heard promises before, so results matter more than announcements.